144 related articles for article (PubMed ID: 9861348)
1. pRb and p16 protein alterations in human oral tumorigenesis.
Pande P; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 1998 Sep; 34(5):396-403. PubMed ID: 9861348
[TBL] [Abstract][Full Text] [Related]
2. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
3. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
6. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
7. Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas.
Koontongkaew S; Chareonkitkajorn L; Chanvitan A; Leelakriangsak M; Amornphimoltham P
Oral Oncol; 2000 Jul; 36(4):334-9. PubMed ID: 10899671
[TBL] [Abstract][Full Text] [Related]
8. Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study.
Chen Q; Luo G; Li B; Samaranayake LP
J Oral Pathol Med; 1999 Apr; 28(4):158-64. PubMed ID: 10235368
[TBL] [Abstract][Full Text] [Related]
9. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
Gorgoulis VG; Koutroumbi EN; Kotsinas A; Zacharatos P; Markopoulos C; Giannikos L; Kyriakou V; Voulgaris Z; Gogas I; Kittas C
Mol Med; 1998 Dec; 4(12):807-22. PubMed ID: 9990866
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in betel and tobacco related oral cancer.
Pande P; Soni S; Kaur J; Agarwal S; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 2002 Jul; 38(5):491-9. PubMed ID: 12110345
[TBL] [Abstract][Full Text] [Related]
11. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
Lim KP; Hamid S; Lau SH; Teo SH; Cheong SC
Oncol Rep; 2007 Jun; 17(6):1321-6. PubMed ID: 17487385
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin dependent kinase inhibitor p21waf1/cip1 in premalignant and malignant oral lesions: relationship with p53 status.
Agarwal S; Mathur M; Shukla NK; Ralhan R
Oral Oncol; 1998 Sep; 34(5):353-60. PubMed ID: 9861340
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of cell cycle-associated proteins p16, pRb, p53, p27 and Ki-67 in oral cancer and precancer with special reference to verrucous carcinomas.
Saito T; Nakajima T; Mogi K
J Oral Pathol Med; 1999 May; 28(5):226-32. PubMed ID: 10226946
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
Muirhead DM; Hoffman HT; Robinson RA
J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing.
Kuttan NA; Rosin MP; Ambika K; Priddy RW; Bhakthan NM; Zhang L
Eur J Cancer B Oral Oncol; 1995 May; 31B(3):169-73. PubMed ID: 7549756
[TBL] [Abstract][Full Text] [Related]
19. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India.
Baral R; Patnaik S; Das BR
Eur J Oral Sci; 1998 Oct; 106(5):907-13. PubMed ID: 9786319
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
